New aspects of chronic beryllium disease
Future directions include development of improved diagnostic biomarkers, refinement of screening protocols, and multicenter trials assessing steroid-sparing regimens. Coordinated translational and occupational research is essential to address persistent diagnostic uncertainty, reduce morbidity, and guide evidence-based management for affected individuals.
Authors
- Maeve G. MacMurdo (ORCID: https://orcid.org/0000-0002-0232-3263)
- Amanda Morgan
Institutions
- Cleveland Clinic (US)
Publication Details
- Journal
- Current Opinion in Allergy and Clinical Immunology
- Published
- 2026-01-13
- DOI
- https://doi.org/10.1097/aci.0000000000001140
- Primary Topic
- Sarcoidosis and Beryllium Toxicity Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00